LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
This Quarter Return
+12.5%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$740M
AUM Growth
+$740M
(+20%)
Cap. Flow
+$52.5M
Cap. Flow
% of AUM
7.1%
Top 10 Holdings %
Top 10 Hldgs %
26.36%
Holding
178
New
36
Increased
70
Reduced
44
Closed
16
Top Buys
| 1 |
Abbott
ABT
|
$11.3M |
| 2 |
McKesson
MCK
|
$11.2M |
| 3 |
Skechers
SKX
|
$6.88M |
| 4 |
Apple
AAPL
|
$6.33M |
| 5 |
Microsoft
MSFT
|
$5.31M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$6.81M |
| 2 |
DexCom
DXCM
|
$5.55M |
| 3 |
Manulife Financial
MFC
|
$5.53M |
| 4 |
Thor Industries
THO
|
$5.2M |
| 5 |
eBay
EBAY
|
$4.13M |
Sector Composition
| 1 | Healthcare | 30.73% |
| 2 | Technology | 18.92% |
| 3 | Consumer Discretionary | 15.6% |
| 4 | Financials | 11.92% |
| 5 | Industrials | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$3.45T
| $32.3M | 4.32% |
167,610
+32,901
| +24% | +$6.33M |
|
|
2
Microsoft
MSFT
$3.77T
| $28.9M | 3.86% |
76,777
+14,127
| +23% | +$5.31M |
|
3
UnitedHealth
UNH
$281B
| $19.3M | 2.58% |
36,599
-5,890
| -14% | -$3.1M |
|
4
IQVIA
IQV
$32.4B
| $18.7M | 2.51% |
81,028
-6,825
| -8% | -$1.58M |
|
5
Service Corp International
SCI
$11.1B
| $17.1M | 2.29% |
250,000
-25,000
| -9% | -$1.71M |
|
|
6
Manulife Financial
MFC
$52.2B
| $16.7M | 2.23% |
754,270
-250,000
| -25% | -$5.53M |
|
7
Merck
MRK
$210B
| $15.7M | 2.1% |
144,324
+7,230
| +5% | +$788K |
|
8
Thermo Fisher Scientific
TMO
$186B
| $15.5M | 2.08% |
29,236
-6,112
| -17% | -$3.24M |
|
9
Brunswick
BC
$4.15B
| $15.5M | 2.07% |
160,000
-15,000
| -9% | -$1.45M |
|
10
Eli Lilly
LLY
$657B
| $15.3M | 2.05% |
26,228
-3,524
| -12% | -$2.05M |
|
11
Amazon
AMZN
$2.44T
| $15.1M | 2.02% |
99,308
+22,624
| +30% | +$3.44M |
|
|
12
Vertex Pharmaceuticals
VRTX
$100B
| $14.7M | 1.97% |
36,127
-16,729
| -32% | -$6.81M |
|
13
NVIDIA
NVDA
$4.24T
| $14.7M | 1.96% |
29,613
+3,230
| +12% | +$1.6M |
|
14
Evolent Health
EVH
$1.12B
| $13.2M | 1.77% |
400,000
+100,000
| +33% | +$3.3M |
|
15
ResMed
RMD
$40.2B
| $12.9M | 1.73% |
75,082
-172
| -0.2% | -$29.6K |
|
|
16
Abbott
ABT
$231B
| $12.6M | 1.68% |
114,243
+103,039
| +920% | +$11.3M |
|
17
Labcorp
LH
$23.1B
| $11.7M | 1.57% |
51,495
-4,188
| -8% | -$952K |
|
18
Ameriprise Financial
AMP
$48.5B
| $11.6M | 1.55% |
30,482
-7,330
| -19% | -$2.78M |
|
19
Hologic
HOLX
$14.9B
| $11.5M | 1.54% |
161,629
+778
| +0.5% | +$55.6K |
|
20
Toll Brothers
TOL
$13.4B
| $11.3M | 1.51% |
110,000
-30,000
| -21% | -$3.08M |
|
|
21
McKesson
MCK
$85.4B
| $11.2M | 1.49% |
+24,119
| New | +$11.2M |
|
22
InMode
INMD
$944M
| $11.1M | 1.48% |
499,000
-9,057
| -2% | -$201K |
|
23
Globe Life
GL
$11.3B
| $11M | 1.47% |
90,000
-15,579
| -15% | -$1.9M |
|
24
Virtus Investment Partners
VRTS
$1.36B
| $10.9M | 1.46% |
45,000
| – | – |
|
25
Option Care Health
OPCH
$4.65B
| $10.8M | 1.44% |
320,000
+120,000
| +60% | +$4.04M |
|